It also signed a contract with a bio-safety center at Korea University's College of Medicine and a joint research team at Cheongju Universit

Korea United Pharmaceutical Co. 가락노래방 said Monday that it has signed a contract to test the effectiveness of its "UI030," which is being developed as a Corona 19 inhalation treatment. During the last clinical application, the Ministry of Food and Drug Safety asked for supplementation, and United imported animals to conduct the "Animal Effectiveness Test of Corona-infected Animals," which was a supplement. 강남더킹 It also signed a contract with a bio-safety center at Korea University's College of Medicine and a joint research team at Cheongju University, and began testing at the same time. An official from Korea United Pharmaceuticals said, "Although the schedule has been delayed than scheduled in the animal import process, 강남미션 we expect the schedule to proceed smoothly afterwards if the test proceeds and the results are produced within the year."